melanosis
Conditions
Interventions
A clinical trial will be conducted at the Aesthetic Health Teaching Laboratory of the State University of Ponta Grossa. The study will involve 30 female participants over the age of 18 with bilateral
Sponsors
Universidade Estadual de Ponta Grossa
Universidade Estadual de Ponta Grossa
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Woman; bilateral facial melasma; over 18 years old; user of SPF 50 sunscreen every 4 hours
Exclusion criteria
Exclusion criteria: Patients under 18 years of age; pregnant and lactating women; patients on any therapy with warfarin, heparin, aspirin or any other anticoagulant medication; patients on vitamin E therapy; patient on hormone replacement therapy or photosensitizing drugs such as tetracycline, spironolactone , phenytoin and carbamazepine; patient with hypersensitivity to the formulations used in the study; patients with bleeding disorders; patient with skin changes such as facial warts, active/recurrent herpes simplex, dermatitis and/or seborrheic, atopic and eczematous dermatosis; patient with a history of keloids or hypertrophic scars; immunocompromised patients; oncology patients; patients with a history of use of oral or topical retinoids, oral tranexamic acid, dermabrasion, laser, surgery, topical bleaching agents, chemical peels performed on the face in the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a better depigmenting effect on the side of the face treated with the peeling evaluated by the peeling and MAsi scale | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactPatrícia Boscardin
Universidade Estadual de Ponta Grossa
Outcome results
None listed